This study is currently not recruiting participants.

A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel Cisplatin and Radiation for Patients with Esophageal Cancer Who are Treated without Surgery

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to compare the effects, good and/or bad, of radiation therapy and chemotherapy (paclitaxel and cisplatin) with or without the addition of cetuximab to find out which treatment is better.

Detailed description of study

The purpose of this study is to compare the effects, good and/or bad, of radiation therapy and chemotherapy (paclitaxel and cisplatin) with or without the addition of cetuximab to find out which treatment is better.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Esophageal
  • Age: 18 years - 100 years
  • Gender: All
Updated on 16 Sep 2011. Study ID: 1010002096

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team